Mitarbeiter: 02 (2023.0)Rechtsform: 5485Größe: PMEGründungsdatum: 2009-07-01 (16 Jahre)Status: AktivBranche: Commerce de détail de produits pharmaceutiques en magasin spécialiséStandort: VILLENEUVE-SAINT-GEORGES (94190), Val-de-Marne
SELARL PHARMACIE ROLAND GARROS : revenue, balance sheet and financial ratios
SELARL PHARMACIE ROLAND GARROS is a French company
founded 16 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in VILLENEUVE-SAINT-GEORGES (94190),
this company of category PME
shows in 2022 a revenue of 1.2 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Historique financier - SELARL PHARMACIE ROLAND GARROS (SIREN 514178136)
Kennzahl
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
Umsatz
N/C
N/C
1 220 506 €
N/C
N/C
N/C
N/C
1 118 208 €
1 070 055 €
1 163 048 €
1 229 693 €
Nettoergebnis
61 791 €
79 675 €
115 554 €
99 648 €
97 488 €
116 622 €
98 881 €
74 021 €
55 931 €
44 956 €
34 154 €
EBITDA
N/C
N/C
146 839 €
N/C
N/C
N/C
N/C
102 590 €
90 275 €
69 601 €
123 361 €
Nettomarge
N/C
N/C
9.5%
N/C
N/C
N/C
N/C
6.6%
5.2%
3.9%
2.8%
Umsatz und Gewinn- und Verlustrechnung
In 2024, SELARL PHARMACIE ROLAND GARROS generates positive net income of 62 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2014-2024: 34 k€ -> 62 k€.
Nettoergebnis (2024)
?
Nettoergebnis
Definition
Bénéfice ou perte après toutes les charges, y compris impôts et éléments exceptionnels.
Le compte de résultat détaillé n'est pas disponible pour cette entreprise (liasse simplifiée ou données confidentielles).
Évolution graphique
Anzeigen :
Visualisierung erstellt mit numbers.finance Sources : INPI & BCE - Anpassungen : Ministère de l'Économie
Aktiva
Chargement des données...
Poste
Brutto
Abschr.
Netto
%
Entwicklung
Données de bilan actif non disponibles pour cette entreprise
Passiva
Chargement des données...
Poste
Jahr
%
Entwicklung
Données de bilan passif non disponibles pour cette entreprise
Solvenz- und Verschuldungskennzahlen
The debt ratio (= Financial debt / Equity x 100) stands at 1%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 86%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Verschuldungsgrad (2024)
?
Verschuldungsgrad
Definition
Misst das Verhältnis von Schulden zu Eigenkapital.
Formel
(Finanzschulden / Eigenkapital) x 100
Interpretation
< 50% : Faible 50-100% : Moderat > 100% : Hoch
0.518%
Finanzielle Autonomie (2024)
?
Finanzielle Autonomie
Definition
Anteil des Eigenkapitals an der Gesamtfinanzierung.
Entwicklung der Solvenzkennzahlen SELARL PHARMACIE ROLAND GARROS
Visualisierung erstellt mit numbers.finance Sources : INPI & BCE - Anpassungen : Ministère de l'Économie
Kennzahl
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Verschuldungsgrad
138.771
110.449
87.438
63.697
39.512
16.998
6.087
0.172
0.558
0.533
0.518
Finanzielle Autonomie
34.615
41.105
47.478
52.923
63.846
73.013
78.99
84.759
86.817
85.86
86.236
Rückzahlungsfähigkeit
12.817
9.612
6.994
5.265
None
None
None
None
0.052
None
None
Cashflow / Umsatz
3.624%
4.543%
6.019%
6.38%
None%
None%
None%
None%
8.762%
None%
None%
Positionnement sectoriel
Debt ratio
0.522024
2022
2023
2024
Q1: 16.45
Méd: 58.41
Q3: 154.59
Excellent
In 2024, the debt ratio of SELARL PHARMACIE ROLAND G... (0.52) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.
Financial autonomy
86.24%2024
2022
2023
2024
Q1: 28.92%
Méd: 49.95%
Q3: 69.49%
Excellent+10 pts über 3 Jahre
In 2024, the financial autonomy of SELARL PHARMACIE ROLAND G... (86.2%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.
Repayment capacity
0.05 years2022
2022
Q1: 1.29 years
Méd: 3.55 years
Q3: 6.63 years
Excellent
In 2022, the repayment capacity of SELARL PHARMACIE ROLAND G... (0.05) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.
Liquiditätskennzahlen
The liquidity ratio (= Current assets / Current liabilities) stands at 278.41. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquiditätsquote (2024)
?
Liquiditätsquote
Definition
Fähigkeit, kurzfristige Schulden mit dem Umlaufvermögen zu decken.
Formel
Umlaufvermögen / Kurzfristige Verbindlichkeiten
Interpretation
> 1.5 : Sehr gut 1-1.5 : Angemessen < 1 : Risque de liquidité
278.408
Entwicklung der Liquiditätskennzahlen SELARL PHARMACIE ROLAND GARROS
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Kennzahl
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Liquiditätsquote
197.316
224.109
258.115
230.043
261.421
190.67
181.166
204.408
271.831
279.543
278.408
Zinsdeckung
19.693
29.741
17.53
12.449
None
None
None
None
0.0
None
None
Positionnement sectoriel
Liquidity ratio
278.412024
2022
2023
2024
Q1: 129.47
Méd: 182.14
Q3: 260.79
Excellent
In 2024, the liquidity ratio of SELARL PHARMACIE ROLAND G... (278.41) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
Interest coverage
0.0x2022
2022
Q1: 0.75x
Méd: 2.51x
Q3: 5.16x
Average
In 2022, the interest coverage of SELARL PHARMACIE ROLAND G... (0.0x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Umlaufvermögensbedarf und Zahlungsfristen
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operatives Working Capital (2024)
?
Operatives Working Capital
Definition
Besoin de financement généré par le cycle d'exploitation (stocks + créances - dettes fournisseurs).
(Lieferantenverbindlichkeiten / Einkäufe inkl. MwSt.) x 360
Interpretation
Je länger die Frist, desto besser für die Liquidität
0 j
Lagerumschlag (2024)
?
Lagerumschlag (Tage)
Definition
Durchschnittliche Lagerdauer für Waren oder Materialien.
Formel
(Vorräte / Einkaufskosten) x 360
Interpretation
Je niedriger das Verhältnis, desto schneller der Umschlag
0 j
Entwicklung des Working Capital und der Zahlungsfristen SELARL PHARMACIE ROLAND GARROS
Visualisierung erstellt mit numbers.finance Sources : INPI & BCE - Anpassungen : Ministère de l'Économie
Kennzahl
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
BFR d'exploitation
209 392 €
195 322 €
202 647 €
176 509 €
0 €
0 €
0 €
0 €
192 205 €
0 €
0 €
Lagerumschlag (Tage)
43
49
43
39
0
0
0
0
38
0
0
Crédit clients (jours)
21
19
21
12
0
0
0
0
17
0
0
Crédit fournisseurs (jours)
52
42
38
49
0
0
0
0
36
0
0
Positionnement de SELARL PHARMACIE ROLAND GARROS dans son secteur
Vergleich mit der Branche Commerce de détail de produits pharmaceutiques en magasin spécialisé
Bewertungsschätzung
Based on 225 transactions of similar company sales
in 2024,
the value of SELARL PHARMACIE ROLAND GARROS is estimated at
862 648 €
(range 600 734€ - 1 290 570€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
600k€862k€1290k€
862 648 €Range: 600 734€ - 1 290 570€
NAF 5 année 2024
Valuation method used
Net Income Multiple
61 791 €
×
14.0x
=862 648 €
Range: 600 734€ - 1 290 571€
Only this financial indicator is available for this company.
Bewertungsentwicklung
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare SELARL PHARMACIE ROLAND GARROS with other companies in the same sector:
Frequently asked questions about SELARL PHARMACIE ROLAND GARROS
What is the revenue of SELARL PHARMACIE ROLAND GARROS ?
The revenue of SELARL PHARMACIE ROLAND GARROS in 2022 is 1.2 M€.
Is SELARL PHARMACIE ROLAND GARROS profitable?
Yes, SELARL PHARMACIE ROLAND GARROS generated a net profit of 62 k€ in 2024.
Where is the headquarters of SELARL PHARMACIE ROLAND GARROS ?
The headquarters of SELARL PHARMACIE ROLAND GARROS is located in VILLENEUVE-SAINT-GEORGES (94190), in the department Val-de-Marne.
Where to find the tax return of SELARL PHARMACIE ROLAND GARROS ?
The tax return of SELARL PHARMACIE ROLAND GARROS is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does SELARL PHARMACIE ROLAND GARROS operate?
SELARL PHARMACIE ROLAND GARROS operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Drehen Sie Ihr Telefon ins Querformat, um das Diagramm anzuzeigen